Stem cells shown safe, beneficial for chronic stroke patients
Autologous mesenchymal stem cells are turning out to be one of the most underappreciated advancements in medicine today, and scandalously the FDA is slowing progress in the field by seeking to prevent doctors from harvesting and reintroducing one's own stem cells back into the body.<p>MSC's can be harvested from one's own adipose tissue with a little bit of liposuction.<p>The process of separating the stem cells from fat is called stromal vascular fraction.<p>It's an astoundingly easy process to do [1]. The equipment is inexpensive, and so far the procedure has been shown to be safe.<p>MSC's have been shown to improve COPD, and reduce the allergic response that triggers asthma. Skin damage healed, cartilage and joint injuries repaired, and even MS put in to remission,<p>MSC's administered via IV flock to areas of inflammation and damage and begin to repair it. The cells know what to do. Local administration is even better, as in this study or in cases of back pain and joint injuries.<p>Autologous treatments should not be considered biological drugs and subject to monopolization by biotech companies through decade long clinical trials and FDA approval.<p>These are our own cells from our own bodies. Doctors should be free to practice and innovate in this sphere, and in this case innovation is mostly just dosage, frequency and delivery method because the cells know what to do.<p>I believe that in the next decade or two, autologous stem cell treatments will be basic preventative care for everyone, a treatment each year will repair damage before it becomes pathology.<p>[1] <a href="https://www.miltenyibiotec.com/~/media/Files/Navigation/Research/Stem%20Cell/SP_MSC_lipoaspirate_protocol.ashx" rel="nofollow">https://www.miltenyibiotec.com/~/media/Files/Navigation/Rese...</a>